🔎 Trials Near Me

Home › Movement Disorders › Maryland

Movement Disorders clinical trials in Maryland

9 studies for Movement Disorders are looking for participants at sites in Maryland.

Cities in Maryland

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

  • National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Nov 12, 2026 · NCT00001208

Deep Brain Stimulation Therapy in Movement Disorders

  • National Institutes of Health Clinical Center, Bethesda
Recruiting
Ages 18 to 100 · All sexes · Updated Nov 12, 2026 · NCT02119611

Deep Brain Stimulation Surgery for Movement Disorders

  • National Institutes of Health Clinical Center, Bethesda
Recruiting
Ages 18 to 99 · All sexes · Updated Nov 12, 2026 · NCT01581580

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

  • Vima Site #043, Baltimore
  • Vima Site #007, Olney
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07804615

Human Movement Database

  • National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
1 Month – 99 Years · All sexes · Updated Oct 29, 2026 · NCT00001252

Genetic Characterization of Movement Disorders and Dementias

  • National Institute of Aging, Clinical Research Unit, Baltimore
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 120 · All sexes · Updated Oct 29, 2026 · NCT02014246

Phenotype/Genotype Correlations in Movement Disorders

  • National Institutes of Health Clinical Center, Bethesda
RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Oct 23, 2026 · NCT00018889

Natural History Protocol for Movement Disorders

  • National Institutes of Health Clinical Center, Bethesda
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 · All sexes · Updated Sep 18, 2026 · NCT05413291

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.